Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer
Agreement will supply Tb-161 for RAD 402, a potential next generation radiopharmaceutical for treatment of…
Agreement will supply Tb-161 for RAD 402, a potential next generation radiopharmaceutical for treatment of…
Agreement will supply Tb-161 for RAD 402, a potential next generation radiopharmaceutical for treatment of…
STOUGHTON, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
STOUGHTON, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
SAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”;…
SAN DIEGO and GAINESVILLE, Ga., Aug. 24, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”;…
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the…
VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) — Digicann Ventures Ltd. (“Digicann” or the…
DOYLESTOWN, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or…
DOYLESTOWN, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or…
SAN DIEGO and TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
SAN DIEGO and TORONTO, Aug. 24, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
– Combined full-year revenue and government support income increased 355% year-over-year – – Received guidance…
– Combined full-year revenue and government support income increased 355% year-over-year – – Received guidance…
Enjoy The Real Fruit Juice Flavours of Solei’s Mango Passionfruit and Dragonfruit Watermelon now Available…
BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company)…
CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC…
ZEDEDA Certified Edge Computing Associate (ZCEA) is a free, vendor-agnostic certification providing fundamental knowledge of…
WALTHAM, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a…
Oomnitza’s inclusion in three recent Gartner Market Guides and six Hype Cycle™, we believe, underscores…